Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

In its upcoming report, Idexx Laboratories (IDXX) is predicted by Wall Street analysts to post quarterly earnings of $2.93 per share, reflecting an increase of 11.8% compared to the same period last ...

Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes ...

Revenue for Q4 2024 was reported at $954 million, surpassing the estimate of $935 million. Q4 EPS came in at $2.62, exceeding the anticipated $2.40. The Companion Animal Group diagnostics segment ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's ...

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Monday posted fourth-quarter earnings and revenue that beat market expectations and issued initial financial guidance for 2025. The Westbrook-based maker of ...

Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus of $2.67. The company reported sales of $964 million, an increase of 7% ...

Aug 4 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab raised its full-year profit and revenue forecasts on Monday after reporting better-than-expected second-quarter results, sending its shares ...

Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...

IDEXX Labs offers veterinary diagnostic instruments, rapid assay test kits, reference lab services, water quality testing products, and veterinary practice management software. The company generates ...

IDEXX Q4 adjusted EPS rose 10% YoY to $2.53, beating the $2.40 estimate. Revenue grew 6% to $954.3M, surpassing the $934.99M consensus. 2025 revenue guidance set at $4.055B–$4.170B vs. $4.14B ...